Similar articles for PMID: 11272298

Year	Number of Results
1991	1
1995	2
1996	5
1997	10
1998	5
1999	13
2000	8
2001	7
2002	4
2003	2
2004	5
2005	6
2006	6
2007	11
2008	4
2009	7
2010	8
2011	5
2012	6
2013	4
2014	6
2015	3
2016	2
2017	3
2018	3
2019	2
2020	3
2021	1
2022	0

1

Plasma viral load testing in the management of HIV infection.

Mylonakis E, Paliou M, Rich JD. Mylonakis E, et al. Am Fam Physician. 2001 Feb 1;63(3):483-90, 495-6. Am Fam Physician. 2001. PMID: 11272298 Free article. Review.

2

Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.

Carr JM, Cheney KM, Coolen C, Davis A, Shaw D, Ferguson W, Chang G, Higgins G, Burrell C, Li P. Carr JM, et al. J Clin Microbiol. 2007 Apr;45(4):1288-97. doi: 10.1128/JCM.01926-06. Epub 2007 Feb 21. J Clin Microbiol. 2007. PMID: 17314225 Free PMC article.

3

Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation.

Raboud JM, Rae S, Hogg RS, Yip B, Sherlock CH, Harrigan PR, O'Shaughnessy MV, Montaner JS. Raboud JM, et al. J Infect Dis. 1999 Oct;180(4):1347-50. doi: 10.1086/314998. J Infect Dis. 1999. PMID: 10479170 Clinical Trial.

4

Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay.

Désiré N, Dehée A, Schneider V, Jacomet C, Goujon C, Girard PM, Rozenbaum W, Nicolas JC. Désiré N, et al. J Clin Microbiol. 2001 Apr;39(4):1303-10. doi: 10.1128/JCM.39.4.1303-1310.2001. J Clin Microbiol. 2001. PMID: 11283046 Free PMC article.

5

The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.

Cardiello P, Srasuebkul P, Hassink E, Mahanontharit A, Samor T, Ruxrungtham K, Lange J, Cooper D, Phanuphak P. Cardiello P, et al. HIV Med. 2005 Mar;6(2):122-8. doi: 10.1111/j.1468-1293.2005.00274.x. HIV Med. 2005. PMID: 15807718 Free article. Clinical Trial.

6

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

Ruiz L, Paredes R, Gómez G, Romeu J, Domingo P, Pérez-Alvarez N, Tambussi G, Llibre JM, Martínez-Picado J, Vidal F, Fumaz CR, Clotet B; TIBET Study Group. Ruiz L, et al. AIDS. 2007 Jan 11;21(2):169-78. doi: 10.1097/QAD.0b013e328011033a. AIDS. 2007. PMID: 17197807 Clinical Trial.

7

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM. Steingrover R, et al. AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77. AIDS. 2008. PMID: 18670217

8

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group. Hoen B, et al. Clin Infect Dis. 2007 Aug 1;45(3):381-90. doi: 10.1086/519428. Epub 2007 Jun 26. Clin Infect Dis. 2007. PMID: 17599319 Free article.

9

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida. Panel de expertos de Gesida y Plan Nacional sobre el Sida. Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.

10

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.

Rusert P, Fischer M, Joos B, Leemann C, Kuster H, Flepp M, Bonhoeffer S, Günthard HF, Trkola A. Rusert P, et al. Virology. 2004 Aug 15;326(1):113-29. doi: 10.1016/j.virol.2004.05.022. Virology. 2004. PMID: 15262500 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed